Dhampur Bio Organics Ltd

DBOLSugar
103.43+0.00 (+0.00%)
As on 30 Jan 2026, 01:38 pmMarket Closed

Fundamental Score

...

Dhampur Bio Organics Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

1.56%
Poor

Return on Capital Employed

3.97%

Operating Profit Margin (5Y)

N/A
Good

Dividend Yield

1.66%

Valuation Metrics

Poor

Price to Earnings

291.81x

Market Capitalization

498.99 (Cr)

Industry P/E

13.17x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

31.58%
Excellent

YoY Quarterly Sales Growth

19.68%

Sales Growth (5Y)

N/A

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Financial Health

Poor

Debt to Equity

0.58x
Poor

Interest Coverage

0.94x
Poor

Free Cash Flow (5Y)

-491.49 (Cr)

Ownership Structure

Good

Promoter Holding

50.65%
Poor

FII Holding

0.35%
Poor

DII Holding

0.45%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
50.65%
Promoter Holding
498.99 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of DBOL across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Robust Profit Growth (31.58%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (19.68%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Balanced Promoter Holding (50.65%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

10 factors identified

Below-Average Return on Equity (1.56%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (3.97%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.

Premium Valuation Risk (P/E: 291.81x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.

Weak Interest Coverage (0.94x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.

Negative Free Cash Flow (₹-491.49 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

Limited Institutional Interest (FII+DII: 0.80%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

Very Low ROE

Observation: Poor capital utilization and shareholder returns.

Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Very High P/E Ratio

Observation: Significant overvaluation risk present.

Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Financial Statements

Comprehensive financial data for Dhampur Bio Organics Ltd

About DBOL

Business Overview

Dhampur Bio Organics Limited, an integrated sugarcane processing company, engages in the manufacture and sale of refined, sulphitation, raw sugar, sugar, biomass-based renewable power, biofuels, potable liquor, chemicals, and allied products in India. The company operates through three segments: Sugar, Bio Fuels & Spirits, and Country Liquor. It also offers alcoholic beverages with 25% and 36% alcohol content; and ENA, a food-grade alcohol, as well as bagasse and organic fertilizer. In addition, the company manufactures and sells SDS, ethanol, sanitizer, etc., as well as engages in the co-generation and sale of power. The company also exports its products. Dhampur Bio Organics Limited was incorporated in 2020 and is based in New Delhi, India.

Company Details

Symbol:DBOL
Industry:Sugar
Sector:Sugar

Key Leadership

Mr. Vijay Kumar Goel
Executive Chairman
Mr. Gautam Goel
CEO, MD & Director
Mr. Nalin Kumar Gupta
Chief Financial Officer

Corporate Events

Recent
Ex-Dividend Date
2025-07-04

DBOL Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)1.56%
Return on Capital Employed3.97%
Operating Profit Margin (5Y)N/A%
Debt to Equity Ratio0.58
Interest Coverage Ratio0.94

Growth & Valuation

Sales Growth (5Y)N/A%
Profit Growth (5Y)N/A%
EPS Growth (5Y)N/A%
YoY Quarterly Profit Growth31.58%
YoY Quarterly Sales Growth19.68%

Frequently Asked Questions

What is the current price of Dhampur Bio Organics Ltd (DBOL)?

As of 30 Jan 2026, 01:38 pm IST, Dhampur Bio Organics Ltd (DBOL) is currently trading at ₹103.43. The stock has a market capitalization of ₹498.99 (Cr).

Is DBOL share price Overvalued or Undervalued?

DBOL is currently trading at a P/E ratio of 291.81x, compared to the industry average of 13.17x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.

What factors affect the Dhampur Bio Organics Ltd share price?

Key factors influencing DBOL's price include its quarterly earnings growth (Sales Growth: 19.68%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Dhampur Bio Organics Ltd a good stock for long-term investment?

Dhampur Bio Organics Ltd shows a 5-year Profit Growth of N/A% and an ROE of 1.56%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.58 before investing.

How does Dhampur Bio Organics Ltd compare with its industry peers?

Dhampur Bio Organics Ltd competes with major peers in the Sugar. Investors should compare DBOL's P/E of 291.81x and ROE of 1.56% against the industry averages to determine its competitive standing.

What is the P/E ratio of DBOL and what does it mean?

DBOL has a P/E ratio of 291.81x compared to the industry average of 13.17x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹292 for every ₹1 of annual earnings.

How is DBOL performing according to Bull Run's analysis?

DBOL has a Bull Run fundamental score of 24.7/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does DBOL belong to?

DBOL operates in the Sugar industry. This classification helps understand the competitive landscape and sector-specific trends affecting Dhampur Bio Organics Ltd.

What is Return on Equity (ROE) and why is it important for DBOL?

DBOL has an ROE of 1.56%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Dhampur Bio Organics Ltd generates profits from shareholders' equity.

How is DBOL's debt-to-equity ratio and what does it indicate?

DBOL has a debt-to-equity ratio of 0.58, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.

What is DBOL's dividend yield and is it a good dividend stock?

DBOL offers a dividend yield of 1.66%, which means you receive ₹1.66 annual dividend for every ₹100 invested.

How has DBOL grown over the past 5 years?

DBOL has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.

What is the promoter holding in DBOL and why does it matter?

Promoters hold 50.65% of DBOL shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is DBOL's market capitalization category?

DBOL has a market capitalization of ₹499 crores, placing it in the Small-cap category.

How volatile is DBOL stock?

DBOL has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for DBOL?

DBOL has a 52-week high of ₹N/A and low of ₹N/A.

What is DBOL's operating profit margin trend?

DBOL has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.

How is DBOL's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 19.68% and YoY Profit Growth of 31.58%.

What is the institutional holding pattern in DBOL?

DBOL has FII holding of 0.35% and DII holding of 0.45%. Significant institutional holding often suggests professional confidence in the stock.